Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy.
Mafong
Derek D
DD
Lee
Grace A
GA
Yu
Siegrid
S
Tien
Phyllis
P
Mauro
Theodora
T
Grunfeld
Carl
C
D015658:HIV Infections / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000150:complications*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008068:Lipomatosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D014157:Transcription Factors / Q000378:metabolism; D016896:Treatment Outcome
D007328:Insulin; D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077154:Rosiglitazone